Skip to content

Steven Madden SHOO Unamortized Discount and Issuance Costs

Unamortized Discount and Issuance Costs at other companies

Blue Owl Capital logo
Blue Owl CapitalOWL
$10.23M+11.8%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$3.52M0.0%
FS KKR Capital Corp. logo
FS KKR Capital Corp.FSK
$30M+15.4%
LPL Financial Holdings logo
LPL Financial HoldingsLPLA
$10.4M
CubeSmart logo
CubeSmartCUBE
$1.5M-37.8%
Blackstone Secured Lending Fund logo
Blackstone Secured Lending FundBXSL
$18.7M-8.8%

Other financials

Income statement

See full
Revenue$653.1M+18.0%
Gross profit$357.4M+58.0%
Operating income$98.7M+84.6%
Net income$71.8M+77.7%
EPS (diluted)$1.00+75.4%

Balance sheet

See full
Cash & equivalents$112.4M-40.8%
Total debt$540.3M+225%
Total equity$913.2M+4.3%
Total assets$2.0B+37.0%

Cash flow

See full
Operating cash flow-$55.3M-194%
CapEx$5.9M-40.1%
Free cash flow-$61.2M-114%

Valuation

See full
Market cap$3.09B+28.3%

Profitability

See full
Gross margin44.8%+3.7pp
Operating margin4.8%-4.9pp
Net margin3.1%-4.5pp
FCF margin3.3%-4.1pp

Returns & leverage

See full
Return on equity9.1%-11.4pp
Debt / equity0.6×+0.4×
Current ratio2.2×0.0×

Where this comes from

Reported directly by Steven Madden in its filing.

Tagged under the XBRL concept us-gaap:DeferredFinanceCostsGross.

The official record: Steven Madden’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Steven Madden's unamortized discount and issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Steven Madden's unamortized discount and issuance costs?
Steven Madden (SHOO) reported unamortized discount and issuance costs of $8.95M in Q4 2025.